Leading clinical trials in ophthalmology, specifically glaucoma, dry-eye, front-of-the-eye, back-of-the-eye, anti-infective, and anti-inflammatory treatments, is second nature for us. Our expertise in this area has been earned over 20 years of clinical research, including that conducted by our founders.
ARG offers a complete range of development services, including drug, drug delivery, medical devices, and preclinical. Atlantic Research Group has managed nearly 300 patients at over 40 sites worldwide. We have decades of cumulative experience in Ophthalmology studies, including but not limited to the following indications: